Article Details

Anaphylaxis Risk Compared for Monoclonal Antibodies Used for Severe Asthma

Retrieved on: 2021-07-02 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Anaphylaxis Risk Compared for Monoclonal Antibodies Used for Severe Asthma. View article details on hiswai:

Excerpt

Patients receiving certain monoclonal antibodies (mAbs) for asthma management should be closely monitored following treatment administration as ...

Article found on: www.empr.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo